• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Peraso Announces First Commercial Order For Its Perspectus mmWave Antenna Modules That Support The DUNE Platform In Dense Urban Environments

    1/24/24 8:13:23 AM ET
    $PRPO
    $PRSO
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Semiconductors
    Technology
    Get the next $PRPO alert in real time by email

    First purchase order validates concept and ability to deliver affordable gigabit wireless to underserved markets

    SAN JOSE, CA / ACCESSWIRE / January 24, 2024 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company") today announced an order for its Perspectus mmWave antenna modules that support the DUNE platform, demonstrating the Company's ability to address broadband infrastructure challenges in informal settlements.

    The DUNE platform implements intelligent Media Access Control features, which, along with the Perspectus series of modules, enable wireless Internet service provider (WISP) operators to deploy long range, multi-point networks without interference in dense user environments. Peraso's latest mmWave antenna module, the PRM2144X, is specifically designed for dense urban areas. A novel 128 element, integrated, phased array antenna, provides high gain, narrow beamwidth and extremely low antenna side-lobes. The increased gain and range also benefit suburban and rural deployments, eliminating the need for dish antennas in many cases.

    "We are very excited about our latest partnership and our opportunity to demonstrate our ability to deliver reliable wireless infrastructure to dense informal settlements at an affordable price point," said Ron Glibbery, CEO of Peraso. "With technology constantly evolving, networks are only getting more congested by the day; however, we believe our license free 60 GHz network solutions will help expand internet access in dense environments."

    Peraso's Perspectus products provide a complete, multi-gigabit, wireless transceiver supporting SuperSpeed USB data connectivity and the IEEE 8021.11ad wireless protocol over the entire 60GHz band from 57 to 71 GHz. The PRM2144X modules are fully tested and ready to integrate. Factory adjustments are not required, as all calibration is performed at run-time.

    For additional information and details about Peraso's latest solutions and capabilities, please visit - https://perasoinc.com/.

    Get the next $PRPO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PRPO
    $PRSO

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $PRPO
    $PRSO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $468 worth of shares (20 units at $23.40), increasing direct ownership by 2% to 1,015 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:22:27 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $488 worth of shares (25 units at $19.50), increasing direct ownership by 3% to 995 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:21:46 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $505 worth of shares (31 units at $16.30), increasing direct ownership by 3% to 970 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:19:49 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $PRPO
    $PRSO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Sullivan James

    4 - Peraso Inc. (0000890394) (Issuer)

    2/10/26 4:51:50 PM ET
    $PRSO
    Semiconductors
    Technology

    SEC Form 4 filed by Chief Executive Officer Glibbery Ronald

    4 - Peraso Inc. (0000890394) (Issuer)

    2/10/26 4:51:37 PM ET
    $PRSO
    Semiconductors
    Technology

    SEC Form 4 filed by Chief Operating Officer Lynch Brad

    4 - Peraso Inc. (0000890394) (Issuer)

    2/10/26 4:51:25 PM ET
    $PRSO
    Semiconductors
    Technology

    $PRPO
    $PRSO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mobix Labs and Peraso Engage in Further Discussions Regarding a Potential Strategic Transaction

    IRVINE, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. (NASDAQ:MOBX) ("Mobix Labs"), a rapidly growing fabless semiconductor and connectivity company serving the defense, aerospace, and high-reliability markets, today announced that it engaged in further discussions with Peraso, Inc. (NASDAQ:PRSO) ("Peraso") regarding a potential strategic transaction. Mobix Labs previously announced that the parties had entered into a mutual confidentiality agreement to support discussions. The parties are conducting customary, confidential diligence. While discussions continue, no agreement has yet been reached regarding transaction structure, consideration, timing, or other material terms.

    1/21/26 7:00:00 AM ET
    $MOBX
    $PRSO
    Semiconductors
    Technology

    Precipio Takes Major Steps Toward a Clean Balance Sheet

    NEW HAVEN, Conn., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) has made major strides in cleaning up its balance sheet with two major accomplishments: 1. Major obligation repaid A $1.1 million advance from Change Healthcare ("CHC"), the Company's clearinghouse service for billing claims processing, has been repaid. CHC experienced a cybersecurity incident in 2024 and advanced Precipio and others funds to cover collections shortfalls. In early January 2026, the Company completed its repayment of that advance. Precipio maintains a small loan with the Connecticut Department of Economic and Community Development in the approximate princ

    1/15/26 9:00:00 AM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

    NEW HAVEN, Conn., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) will be presenting at ASH the findings of a joint study conducted with scientific collaborators from Memorial Sloan Kettering in New York, evaluating Precipio's BCR::ABL1 assay. The data from a comprehensive study includes 895 patient samples and demonstrates superior performance of the assay, while showing concordance with two other leading platforms. The study shows clear, positive impacts on patient care alongside substantial improvements in laboratory workflows. Poster presentation of the study abstract, and results discussion are scheduled for Monday December 8th fro

    12/5/25 10:00:00 AM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $PRPO
    $PRSO
    SEC Filings

    View All

    Peraso Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Peraso Inc. (0000890394) (Filer)

    2/13/26 4:32:56 PM ET
    $PRSO
    Semiconductors
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Precipio Inc.

    SCHEDULE 13G/A - Precipio, Inc. (0001043961) (Subject)

    2/10/26 3:19:41 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form S-8 filed by Precipio Inc.

    S-8 - Precipio, Inc. (0001043961) (Filer)

    1/26/26 5:08:49 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $PRPO
    $PRSO
    Leadership Updates

    Live Leadership Updates

    View All

    Peraso Announces Appointment of Nadine Hatto to GigFire Advisory Board

    Solidifies Key WISP Relationship for Collaborative Expansion in the 60 GHz Wireless Access MarketSAN JOSE, CA / ACCESSWIRE / April 13, 2023 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company"), a leader in mmWave technology for 60 GHz unlicensed and 5G licensed networks, is pleased to announce that Nadine Hatto, has joined the Advisory Board of GigFire, a leading wireless internet service provider (WISP) in the Midwestern United States.In addition to possessing extensive telecommunications industry knowledge and expertise, Dr. Hatto's appointment to the Advisory Board further strengthens the relationship between GigFire and Peraso. GigFire is focused on expanding into new markets and offe

    4/13/23 8:00:00 AM ET
    $PRSO
    Semiconductors
    Technology

    Peraso Appoints Mark Lunsford as Chief Revenue Officer

    SAN JOSE, CA / ACCESSWIRE / October 25, 2022 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company"), a leader in mmWave technology for 5G networks, announced today that it has named Mark Lunsford to the position of Chief Revenue Officer. Lunsford will be responsible for sales, business development and strategic partnership efforts."Mark brings a deep understanding of leading-edge technologies and has demonstrated success across companies at various stages of growth," said Ron Glibbery, CEO of Peraso. "We were particularly drawn to his prior experience at emerging growth companies, where he helped convert groundbreaking technology into large, multi-million dollar sales pipelines. While in ot

    10/25/22 9:00:00 AM ET
    $PRSO
    Semiconductors
    Technology

    Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFO

    NEW HAVEN, Conn., March 21, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced that Mr. Carl Iberger, Precipio's CFO for the past five years, is resigning as the Chief Financial Officer effective as of today, March 21st, 2022. Mr. Iberger wishes to spend more time with his family and therefore has made the decision to step down from his role as CFO. Matt Gage, who currently serves as Director of Financial Reporting and Analysis has been promoted to Interim Chief Financial Officer of the Company effective immediately. Mr. Gage joined Precipio following its acquisition of Transgenomic in July of 2017. He has worked closely with Mr. Ib

    3/21/22 5:00:00 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $PRPO
    $PRSO
    Financials

    Live finance-specific insights

    View All

    Precipio Takes Major Steps Toward a Clean Balance Sheet

    NEW HAVEN, Conn., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) has made major strides in cleaning up its balance sheet with two major accomplishments: 1. Major obligation repaid A $1.1 million advance from Change Healthcare ("CHC"), the Company's clearinghouse service for billing claims processing, has been repaid. CHC experienced a cybersecurity incident in 2024 and advanced Precipio and others funds to cover collections shortfalls. In early January 2026, the Company completed its repayment of that advance. Precipio maintains a small loan with the Connecticut Department of Economic and Community Development in the approximate princ

    1/15/26 9:00:00 AM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

    NEW HAVEN, Conn., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) will be presenting at ASH the findings of a joint study conducted with scientific collaborators from Memorial Sloan Kettering in New York, evaluating Precipio's BCR::ABL1 assay. The data from a comprehensive study includes 895 patient samples and demonstrates superior performance of the assay, while showing concordance with two other leading platforms. The study shows clear, positive impacts on patient care alongside substantial improvements in laboratory workflows. Poster presentation of the study abstract, and results discussion are scheduled for Monday December 8th fro

    12/5/25 10:00:00 AM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

    NEW HAVEN, Conn., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Precipio, Inc. reports that the Company recently identified a single, limited scope unauthorized access to a specific data folder stored within its secure cloud file environment. The incident was limited to its file storage server and did not impact any of Precipio's operations, diagnostics processes, or customer services, and the company continued to provide its services unhindered. There was no impact to patient care; nor impact to the company's operations or finances. Upon detecting the activity, the Company immediately initiated its incident response procedures and engaged an external cybersecurity law firm and forensic specialists t

    12/4/25 8:00:00 AM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $PRPO
    $PRSO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Peraso Inc.

    SC 13G/A - Peraso Inc. (0000890394) (Subject)

    11/14/24 4:45:03 PM ET
    $PRSO
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by Peraso Inc.

    SC 13G/A - Peraso Inc. (0000890394) (Subject)

    11/14/24 4:02:21 PM ET
    $PRSO
    Semiconductors
    Technology

    SEC Form SC 13G filed by Precipio Inc.

    SC 13G - Precipio, Inc. (0001043961) (Subject)

    8/2/24 2:15:53 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials